Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial fibrillation: results from the ARISTOTLE Trial
Publication
, Conference
Flaker, G; Lopes, R; Al-Khatib, S; Hermosillo, A; Thomas, L; Zhu, J; Ruzyllo, W; Mohan, P; Granger, C; Wallentin, L
Published in: EUROPEAN HEART JOURNAL
August 1, 2012
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
August 1, 2012
Volume
33
Start / End Page
686 / 686
Location
Munchen, GERMANY
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Flaker, G., Lopes, R., Al-Khatib, S., Hermosillo, A., Thomas, L., Zhu, J., … Wallentin, L. (2012). Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial fibrillation: results from the ARISTOTLE Trial. In EUROPEAN HEART JOURNAL (Vol. 33, pp. 686–686). Munchen, GERMANY: OXFORD UNIV PRESS.
Flaker, G., R. Lopes, S. Al-Khatib, A. Hermosillo, L. Thomas, J. Zhu, W. Ruzyllo, P. Mohan, C. Granger, and L. Wallentin. “Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial fibrillation: results from the ARISTOTLE Trial.” In EUROPEAN HEART JOURNAL, 33:686–686. OXFORD UNIV PRESS, 2012.
Flaker G, Lopes R, Al-Khatib S, Hermosillo A, Thomas L, Zhu J, et al. Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial fibrillation: results from the ARISTOTLE Trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2012. p. 686–686.
Flaker, G., et al. “Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial fibrillation: results from the ARISTOTLE Trial.” EUROPEAN HEART JOURNAL, vol. 33, OXFORD UNIV PRESS, 2012, pp. 686–686.
Flaker G, Lopes R, Al-Khatib S, Hermosillo A, Thomas L, Zhu J, Ruzyllo W, Mohan P, Granger C, Wallentin L. Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial fibrillation: results from the ARISTOTLE Trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2012. p. 686–686.
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
August 1, 2012
Volume
33
Start / End Page
686 / 686
Location
Munchen, GERMANY
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology